Convalescent Plasma for Patients With Severe Coronavirus Disease 2019 (COVID-19): A Matched Cohort Study

BACKGROUND: The efficacy of convalescent plasma (CP) for the treatment of coronavirus disease 2019 (COVID-19) remains unclear. METHODS: In a matched cohort analysis of hospitalized patients with severe COVID-19, the impact of CP treatment on in-hospital mortality was evaluated using univariate and m...

Descripción completa

Detalles Bibliográficos
Autores principales: Rogers, Ralph, Shehadeh, Fadi, Mylona, Evangelia K, Rich, Josiah, Neill, Marguerite, Touzard-Romo, Francine, Geffert, Sara, Larkin, Jerome, Bailey, Jeffrey A, Lu, Shaolei, Sweeney, Joseph, Mylonakis, Eleftherios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Online Only Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665324/
https://www.ncbi.nlm.nih.gov/pubmed/33038227
http://dx.doi.org/10.1093/cid/ciaa1548

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665324/
https://www.ncbi.nlm.nih.gov/pubmed/33038227
http://dx.doi.org/10.1093/cid/ciaa1548

Ejemplares similares